Awareness of the Risk of Paradoxical Psoriasis in Patients with SAPHO Syndrome Undergoing Treatment with Secukinumab: A Case Series
Journal of Inflammation Research · 2025-03 · Volume 18 · 3705-3712
DOI: 10.2147/jir.s510006 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Inflammation Research, 2025-03. Verfasst von Cheng Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
ORCID-Profile: Cheng Xu
Zitieren
APA
Xu, C., Xu, X., & Han, Y. (2025). Awareness of the Risk of Paradoxical Psoriasis in Patients with SAPHO Syndrome Undergoing Treatment with Secukinumab: A Case Series. Journal of Inflammation Research, Volume 18, 3705-3712. https://doi.org/10.2147/jir.s510006
Vancouver
Xu C, Xu X, Han Y. Awareness of the Risk of Paradoxical Psoriasis in Patients with SAPHO Syndrome Undergoing Treatment with Secukinumab: A Case Series. Journal of Inflammation Research. 2025;Volume 18:3705-3712. doi:10.2147/jir.s510006
BibTeX
@article{Xu2025,
author = {Xu, Cheng and Xu, Xiayan and Han, Yongmei},
title = {Awareness of the Risk of Paradoxical Psoriasis in Patients with SAPHO Syndrome Undergoing Treatment with Secukinumab: A Case Series},
journal = {Journal of Inflammation Research},
year = {2025},
volume = {Volume 18},
pages = {3705--3712},
doi = {10.2147/jir.s510006}
}
EUVIMED